About

Reimbursement for wound care products across Europe remains highly heterogeneous, driven by differences in healthcare organisation, regulatory frameworks, and coverage criteria. Improving transparency within this complex landscape is therefore a strategic, long-term endeavor.

This second edition of the EWMA Reimbursement Report expands both the geographical and practical scope of the initiative, with new contributions from Germany, Ireland, and Lithuania. Several countries have also strengthened their input by clarifying procedures for companies seeking reimbursement, while others have updated previously published information.

In line with EWMA’s 2025–2027 strategy, this work represents an incremental but purposeful approach, developed through close partnership with national wound management associations, academic institutions, and other relevant stakeholders.

Collaborating Organizations and Editors: www.ewma.org/coop-organisations/